177 related articles for article (PubMed ID: 35340220)
21. Role of Anillin in Tumour: From a Prognostic Biomarker to a Novel Target.
Tuan NM; Lee CH
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560530
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Pan-Cancer Analysis Confirmed That ATG5 Promoted the Maintenance of Tumor Metabolism and the Occurrence of Tumor Immune Escape.
Xu C; Zang Y; Zhao Y; Cui W; Zhang H; Zhu Y; Xu M
Front Oncol; 2021; 11():652211. PubMed ID: 33842365
[TBL] [Abstract][Full Text] [Related]
23. Anillin governs mitotic rounding during early epidermal development.
Mahly A; Padmanabhan K; Soffer A; Cohen J; Omar J; Sagi-Eisenberg R; Luxenburg C
BMC Biol; 2022 Jun; 20(1):145. PubMed ID: 35710398
[TBL] [Abstract][Full Text] [Related]
24. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
25. Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis.
Nie Y; Zhao Z; Chen M; Ma F; Fan Y; Kang Y; Kang B; Wang C
Oncol Lett; 2021 Feb; 21(2):107. PubMed ID: 33376540
[TBL] [Abstract][Full Text] [Related]
26. Subcellular localisation of anillin is associated with different survival outcomes in upper urinary tract urothelial carcinoma.
Liang PI; Chen WT; Li CF; Li CC; Li WM; Huang CN; Yeh HC; Ke HL; Wu WJ; Chai CY
J Clin Pathol; 2015 Dec; 68(12):1026-32. PubMed ID: 26135313
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients.
Wang Z; Chen J; Zhong MZ; Huang J; Hu YP; Feng DY; Zhou ZJ; Luo X; Liu ZQ; Jiang WZ; Zhou WB
Cancer Chemother Pharmacol; 2017 Mar; 79(3):535-543. PubMed ID: 28243684
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Analysis of RELL2 as a Potential Biomarker Associated with Tumor Immune Infiltrating Cells in a Pan-Cancer Analysis.
Musha K; Ge X; Ablikim N; Lu B; Chen C; Huang J
Dis Markers; 2022; 2022():5009512. PubMed ID: 35634441
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of ANLN in lung adenocarcinoma.
Long X; Zhou W; Wang Y; Liu S
Oncol Lett; 2018 Aug; 16(2):1835-1840. PubMed ID: 30008873
[TBL] [Abstract][Full Text] [Related]
30. ANLN promotes carcinogenesis in oral cancer by regulating the PI3K/mTOR signaling pathway.
Wang B; Zhang XL; Li CX; Liu NN; Hu M; Gong ZC
Head Face Med; 2021 Jun; 17(1):18. PubMed ID: 34082790
[TBL] [Abstract][Full Text] [Related]
31. Screening
Yang T; Chi Z; Liu G; Hong X; Cao S; Cheng K; Zhang Y
Front Genet; 2023; 14():1107625. PubMed ID: 37051591
[No Abstract] [Full Text] [Related]
32. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
[TBL] [Abstract][Full Text] [Related]
33. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J
Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment.
Ji H; Ren M; Liu T; Sun Y
Dis Markers; 2021; 2021():5350232. PubMed ID: 34840630
[TBL] [Abstract][Full Text] [Related]
35. Pan-Cancer Analysis Revealed
Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
[TBL] [Abstract][Full Text] [Related]
36. Dysregulated ANLN reveals immune cell landscape and promotes carcinogenesis by regulating the PI3K/Akt/mTOR pathway in clear cell renal cell carcinoma.
Gao M; Tuo Z; Jiang Z; Chen Z; Wang J
Heliyon; 2024 Jan; 10(1):e23522. PubMed ID: 38173514
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
39. Pan-Cancer Analysis Based on
Zhang Y; Wang S; Han S; Feng Y
Front Oncol; 2022; 12():844794. PubMed ID: 35359375
[TBL] [Abstract][Full Text] [Related]
40. High mobility group AT-hook 2 promotes tumorigenicity of pancreatic cancer cells via upregulating ANLN.
Guo HH; Wang YZ; Zhang ZK; Li MZ; Tian XD; Yang YM
Exp Cell Res; 2020 Aug; 393(1):112088. PubMed ID: 32413362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
